Although PIAS has been shown to enhance the transcriptional activity of androgen receptors (AR) in prostate cancer cells, other studies have revealed that ectopic overexpression of PIAS3 suppresses AR-mediated gene activation induced by dihydrotestosterone (DHT) [24]. Here, PIAS3 is linked to prostate carcinoma.